Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$183M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Howe Jolanda | Nov 14, 2024 | Sell | 2,500 | $47.1008 | $120,000 |
| Heron Patrick J | Sep 18, 2024 | Buy | 115 | $37.4 | $4,300 |
| Heron Patrick J | Sep 6, 2024 | Buy | 230 | $41.5783 | $9,600 |
| Howe Jolanda | Jul 2, 2024 | Sell | 375 | $34 | $13,000 |
| Vig Pamela | Jun 24, 2024 | Sell | 30,559 | $34 | $1M |
| Ramasastry Saira | Jun 5, 2024 | Sell | 5,000 | $25.68 | $130,000 |
| BJERKHOLT ERIC | Mar 27, 2024 | Buy | 2,000 | $24.8 | $50,000 |
| Radovich Peter | Mar 25, 2024 | Sell | 4,303 | $25.8 | $110,000 |
| BJERKHOLT ERIC | Mar 18, 2024 | Buy | 2,000 | $25.8 | $52,000 |
| Vig Pamela | Feb 2, 2024 | Sell | 1,214 | $26.1918 | $32,000 |
| Radovich Peter | Feb 2, 2024 | Sell | 1,790 | $26.1917 | $47,000 |
| Peetz Christopher | Feb 2, 2024 | Sell | 6,013 | $26.1918 | $160,000 |
| Longpre Lara | Feb 2, 2024 | Sell | 847 | $26.1918 | $22,000 |
| Howe Jolanda | Feb 2, 2024 | Sell | 735 | $26.1918 | $19,000 |
| Radovich Peter | Jan 8, 2024 | Sell | 1,408 | $28.0345 | $39,000 |
| Longpre Lara | Jan 8, 2024 | Sell | 1,019 | $28.035 | $29,000 |
| Vig Pamela | Jan 8, 2024 | Sell | 1,408 | $28.0343 | $39,000 |
| Peetz Christopher | Jan 8, 2024 | Sell | 5,209 | $28.0348 | $150,000 |
| Howe Jolanda | Jan 8, 2024 | Sell | 528 | $28.0351 | $15,000 |
| Howe Jolanda | Dec 5, 2023 | Sell | 2,500 | $32.4 | $81,000 |
| Heron Patrick J | Nov 9, 2023 | Buy | 2,910 | $28.3 | $82,000 |
| GREY MICHAEL G | Sep 14, 2023 | Sell | 14,216 | $32 | $450,000 |
| Heron Patrick J | Sep 13, 2023 | Buy | 2,625 | $31.019 | $81,000 |
| GREY MICHAEL G | Sep 13, 2023 | Sell | 392 | $32 | $13,000 |
| Heron Patrick J | Sep 12, 2023 | Buy | 3,750 | $30.6037 | $110,000 |
| BJERKHOLT ERIC | Sep 11, 2023 | Buy | 10,000 | $29.6492 | $300,000 |
| Heron Patrick J | Sep 11, 2023 | Buy | 4,687 | $30.3024 | $140,000 |
| Heron Patrick J | Aug 31, 2023 | Buy | 147,991 | $26.25 | $3.9M |
| Howe Jolanda | Aug 25, 2023 | Sell | 3,459 | $26.2339 | $91,000 |
| Radovich Peter | Jul 3, 2023 | Sell | 1,425 | $25.6466 | $37,000 |
| Longpre Lara | Jul 3, 2023 | Sell | 1,004 | $25.6466 | $26,000 |
| Vig Pamela | Jul 3, 2023 | Sell | 1,425 | $25.6466 | $37,000 |
| Peetz Christopher | Jul 3, 2023 | Sell | 5,498 | $25.6466 | $140,000 |
| Howe Jolanda | Jul 3, 2023 | Sell | 915 | $25.6466 | $23,000 |
| GREY MICHAEL G | Jun 8, 2023 | Sell | 14,608 | $29 | $420,000 |
| GREY MICHAEL G | May 3, 2023 | Sell | 14,608 | $28 | $410,000 |
| Radovich Peter | Jan 9, 2023 | Sell | 1,379 | $20.6223 | $28,000 |
| Vig Pamela | Jan 9, 2023 | Sell | 1,379 | $20.6223 | $28,000 |
| Longpre Lara | Jan 9, 2023 | Sell | 1,003 | $20.6223 | $21,000 |
| Peetz Christopher | Jan 9, 2023 | Sell | 5,159 | $20.6223 | $110,000 |
What's the latest insider transaction for Mirum Pharmaceuticals?
The most recent insider transaction for Mirum Pharmaceuticals was conducted by Howe Jolanda, who sold 2,500 shares on November 14, 2024 at a price of $47.10 per share.
Which insider bought the most MIRM stock over the last two years?
Heron Patrick J has bought the most MIRM stock in the last 2 years, with a total value of $4.3M.
Which insider has sold the most MIRM stock over the last two years?
GREY MICHAEL G has sold the most MIRM stock in the last 2 years, with a total value of $1.3M.
What is the total value of insider transactions for Mirum Pharmaceuticals (MIRM) in the last 2 years?
According to our estimates, the total value of insider transactions for Mirum Pharmaceuticals in the last 2 years is positive, amounting to $840,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Mirum Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Mirum Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
